Literature DB >> 21421745

Depression and explicit requests for euthanasia in end-of-life cancer patients in primary care in the Netherlands: a longitudinal, prospective study.

Cees D M Ruijs1, A J F M Kerkhof, G van der Wal, B D Onwuteaka-Philipsen.   

Abstract

BACKGROUND: In the Netherlands, many (45%) cancer patients die at home, in the care of GPs. About 1 out of 10 end-of-life cancer deaths is hastened by GPs through euthanasia or physician-assisted suicide. However, the relationship between depression and requests for euthanasia has never been prospectively studied directly in primary care.
OBJECTIVE: This study aimed to assess the prevalence of depression in end-of-life cancer patients requesting euthanasia in primary care, as well as to assess the relationship between depression and requesting euthanasia.
METHODS: Primary care patients with incurable cancer and an estimated life expectancy of half a year or shorter were interviewed every 2 months, using standardized psychometric instruments. Also, non-recruited eligible patients were monitored.
RESULTS: Out of 258 eligible patients, 76 patients were recruited, of whom 64 patients were followed up until death. Of these, 27% (n = 17) explicitly requested euthanasia. One patient suffered from major depression. According to the depression subscale of the Hospital Anxiety and Depression Scale, 47% of the patients who explicitly requested euthanasia versus 28% of those without an euthanasia request suffered from a depressed mood at inclusion; the difference was not significant (P = 0.2). Corresponding figures for the last interview before death were 40% and 41% (P = 0.6).
CONCLUSIONS: Major depression was not a major factor in explicit requests for euthanasia in end-of-life cancer patients in primary care. Further depressed mood was not associated with explicitly requesting euthanasia in this patient group, although statistical underpower cannot be ruled out in this small sample.

Entities:  

Mesh:

Year:  2011        PMID: 21421745     DOI: 10.1093/fampra/cmr006

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  7 in total

1.  Symptoms and medication management in the end of life phase of high-grade glioma patients.

Authors:  J A F Koekkoek; L Dirven; E M Sizoo; H R W Pasman; J J Heimans; T J Postma; L Deliens; R Grant; S McNamara; G Stockhammer; E Medicus; M J B Taphoorn; J C Reijneveld
Journal:  J Neurooncol       Date:  2014-08-24       Impact factor: 4.130

2.  Unbearable suffering and requests for euthanasia prospectively studied in end-of-life cancer patients in primary care.

Authors:  Cees Dm Ruijs; Gerrit van der Wal; Ad Jfm Kerkhof; Bregje D Onwuteaka-Philipsen
Journal:  BMC Palliat Care       Date:  2014-12-23       Impact factor: 3.234

3.  [Mortality in schizophrenia: Towards a new health scandal? COVID-19 and schizophrenia].

Authors:  Guillaume Fond; Pierre-Michel Llorca; Christophe Lançon; Pascal Auquier; Laurent Boyer
Journal:  Ann Med Psychol (Paris)       Date:  2021-02-17       Impact factor: 0.380

4.  Letter on: "Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population".

Authors:  Ahmad Amjed Toubasi
Journal:  Schizophr Res       Date:  2021-06-26       Impact factor: 4.939

5.  The broad spectrum of unbearable suffering in end-of-life cancer studied in dutch primary care.

Authors:  Cees Dm Ruijs; Ad Jfm Kerkhof; Gerrit van der Wal; Bregje D Onwuteaka-Philipsen
Journal:  BMC Palliat Care       Date:  2012-08-01       Impact factor: 3.234

6.  Symptoms, unbearability and the nature of suffering in terminal cancer patients dying at home: a prospective primary care study.

Authors:  Cees D M Ruijs; Ad J F M Kerkhof; Gerrit van der Wal; Bregje D Onwuteaka-Philipsen
Journal:  BMC Fam Pract       Date:  2013-12-28       Impact factor: 2.497

7.  Depressive and anxiety symptoms among Japanese cancer survivors: Japan cancer survivorship research project.

Authors:  Motoki Endo; Kentaro Matsui; Rie Akaho; Kiyomi Mitsui; Yan Yan; Yuya Imai; Yuito Ueda; Go Muto; Gautam A Deshpande; Yasuhisa Terao; Satoru Takeda; Mitsue Saito; Kazuhiko Hayashi; Katsuji Nishimura; Takeshi Tanigawa
Journal:  BMC Cancer       Date:  2022-02-02       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.